ESMO 2021 Roundup
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2021 Roundup ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
22 Sep 2021
OncoAlert and ecancer - ESMO 2021 Day 5
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer - ESMO 2021 Day 5 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
21 Sep 2021
OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
23 Aug 2021
Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative ch...
Prof John Reynolds - Trinity College Dublin, Dublin, Republic of Ireland
Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy ( Prof John Reynolds - Trinity College Dublin, Dublin, Republic of Ireland )
29 Jun 2021
COSMIC-311: Cabozantinib versus placebo in patients with radioiodine-refractory ...
Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA
COSMIC-311: Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer ( Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA )
29 Jun 2021
Highlights from ASCO 2021
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ASCO 2021 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
8 Jun 2021
OncoAlert and ecancer ASCO roundup - Day 3
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer ASCO roundup - Day 3 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Jun 2021
Incidence and trends of HPV-related cancers in the United States
Dr John Chan - UCSF Helen Diller Family Comprehensive Cancer Center, San Francis...
Incidence and trends of HPV-related cancers in the United States ( Dr John Chan - UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA )
4 Jun 2021
Nivolumab plus ipilimumab or NIVO plus chemo versus chemo as firstline for advan...
Dr Ian Chau - The Royal Marsden, London, UK
Nivolumab plus ipilimumab or NIVO plus chemo versus chemo as firstline for advanced ESCC ( Dr Ian Chau -  The Royal Marsden, London, UK )
4 Jun 2021
OncoAlert and ecancer weekly roundup for April 19 - 25, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for April 19 - 25, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
26 Apr 2021
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
9 Feb 2021
2020 updates in treating NTRK fusion cancer
Dr Alexander Drilon and Prof Marc Peeters
2020 updates in treating NTRK fusion cancer ( Dr Alexander Drilon and Prof Marc Peeters )
22 Dec 2020